Ming Han1, Hua-Yu Deng, Rong Jiang. 1. Department of Pathophysiology, Laboratory for Stem Cell and Tissue Engineering, Chongqing Medical University, Chongqing 400016, China.
Abstract
OBJECTIVE: To investigate the effects and mechanisms of trastuzumab on Notch-1 pathway in breast cancer cells, recognizing the significance of Notch-1 signaling pathway in trastuzumab resistance. METHODS: Immunocytochemistry staining and Western blotting were employed to justify the expression of Notch-1 protein in HER2-overexpressing SK-BR3 cells and HER2-non-overexpressing breast cancer MDA-MB-231 cells. Western blotting and reverse transcription PCR (RT-PCR) were used to detect the activated Notch-1 and Notch-1 target gene HES-1 mRNA expression after SK-BR3 cells were treated with trastuzumab. Double immunofluorescence staining and co-immunoprecipitation were used to analyze the relationship of Notch-1 and HER2 proteins. RESULTS: The level of Notch-1 nuclear localization and activated Notch-1 proteins in HER2-overexpressing cells were significantly lower than in HER2-non-overexpressing cells (P<0.01), and the expressions of activated Notch-1 and HES-1 mRNA were obviously increased after trastuzumab treatment (P<0.05), but HER2 expression did not change significantly for trastuzumab treating (P>0.05). Moreover, Notch-1 was discovered to co-localize and interact with HER2 in SK-BR3 cells. CONCLUSION: Overexpression of HER2 decreased Notch-1 activity by the formation of a HER2-Notch1 complex, and trastuzumab can restore the activity of Notch-1 signaling pathway, which could be associated with cell resistance to trastuzumab.
OBJECTIVE: To investigate the effects and mechanisms of trastuzumab on Notch-1 pathway in breast cancer cells, recognizing the significance of Notch-1 signaling pathway in trastuzumab resistance. METHODS: Immunocytochemistry staining and Western blotting were employed to justify the expression of Notch-1 protein in HER2-overexpressing SK-BR3 cells and HER2-non-overexpressing breast cancer MDA-MB-231 cells. Western blotting and reverse transcription PCR (RT-PCR) were used to detect the activated Notch-1 and Notch-1 target gene HES-1 mRNA expression after SK-BR3 cells were treated with trastuzumab. Double immunofluorescence staining and co-immunoprecipitation were used to analyze the relationship of Notch-1 and HER2 proteins. RESULTS: The level of Notch-1 nuclear localization and activated Notch-1 proteins in HER2-overexpressing cells were significantly lower than in HER2-non-overexpressing cells (P<0.01), and the expressions of activated Notch-1 and HES-1 mRNA were obviously increased after trastuzumab treatment (P<0.05), but HER2 expression did not change significantly for trastuzumab treating (P>0.05). Moreover, Notch-1 was discovered to co-localize and interact with HER2 in SK-BR3 cells. CONCLUSION: Overexpression of HER2 decreased Notch-1 activity by the formation of a HER2-Notch1 complex, and trastuzumab can restore the activity of Notch-1 signaling pathway, which could be associated with cell resistance to trastuzumab.
Entities:
Keywords:
Breast cancer; HER2; Notch-1; Trastuzumab
Authors: Debashish Das; Fredrik Lanner; Heather Main; Emma R Andersson; Olaf Bergmann; Cecilia Sahlgren; Nina Heldring; Ola Hermanson; Emil M Hansson; Urban Lendahl Journal: Dev Biol Date: 2010-09-29 Impact factor: 3.582
Authors: Roberto Gennari; Sylvie Menard; Francesco Fagnoni; Luisa Ponchio; Mario Scelsi; Elda Tagliabue; Fabio Castiglioni; Laura Villani; Cesare Magalotti; Nadia Gibelli; Barbara Oliviero; Bettina Ballardini; Gianantonio Da Prada; Alberto Zambelli; Alberto Costa Journal: Clin Cancer Res Date: 2004-09-01 Impact factor: 12.531
Authors: Rupert Bartsch; Catharina De Vries; Ursula Pluschnig; Peter Dubsky; Zsuzsanna Bago-Horvath; Simon P Gampenrieder; Margaretha Rudas; Robert M Mader; Andrea Rottenfusser; Christoph Wiltschke; Michael Gnant; Christoph C Zielinski; Guenther G Steger Journal: BMC Cancer Date: 2009-10-17 Impact factor: 4.430